DBVT

#2293
DBV Technologies S.A.
21.68 USD
+0.18%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
21.59
21.95
Rango anual
7.26
26.19
Cambio diario
+0.18%
Variación mensual
+5.81%
Variación en los últimos 6 meses
+25.54%
Cambio anual
+191.40%
Cierres anteriores
21.64
Abrir
21.95
Bid
Ask
Mínimo
21.59
High
21.95
Volumen
51
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

DBV Technologies S.A. - American Depositary Shares

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

Noticias